Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.995    -0.215 (-9.73%)
Bid:
1.905
Ask:
2.19
Spread: 0.285 (14.961%)
Market Cap: £40.02m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Form 8.5 (EPT/NON-RI) AMENDMENT - QUINTAIN ESTATES & DEVELOPMENT PLC

28 Aug 2015 16:56

FORM 8.5 (EPT/NON-RI) AMENDMENT TO PURCHASES

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (“RI”) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader: BARCLAYS CAPITAL SECURITIES LTD
(b) Name of offeror/offeree in relation to whose QUINTAIN ESTATES & DEVELOPMENT PLC
relevant securities this form relates:
(c) Name of the party to the offer with which exempt QUINTAIN ESTATES & DEVELOPMENT PLC
principal trader is connected
(d) Date position held/dealing undertaken: 24 August 2015
(e) In addition to the company in 1(b) above, is the exempt principal NO
trader making disclosures in respect of any other party to the offer?

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 1,802,696 0.21% 704,194 0.13%
(2) Cash-settled derivatives:
0 0.00% 760,376 0.14%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 1,802,696 0.21% 1,464,570 0.28%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
ORD Purchase 714,800 1.3000 GBP 1.2992 GBP
ORD Sale 701,542 1.3001 GBP 1.3 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD CFD Short 13,258 1.2992 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 28 Aug 2015
Contact name: Jay Supaya
Telephone number: 020 7773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150828005468/en/

Copyright Business Wire 2015

Date   Source Headline
24th May 20127:00 amRNSFinal Results - Part 2
24th May 20127:00 amRNSFinal Results - Part 1
23rd May 20127:00 amRNSiQ Fund agrees further £70m financing with M&G
15th May 20123:23 pmRNSDirector/PDMR Shareholding
14th May 201210:52 amRNSNotice of Preliminary Results
4th May 20124:02 pmRNSDirector/PDMR Shareholding
30th Apr 201210:35 amRNSBlocklisting Interim Review
3rd Apr 20127:00 amRNSiQ Fund Agrees £158 million refinancing
2nd Apr 201210:32 amRNSTotal Voting Rights
29th Mar 20127:00 amRNSSale of Emersons Green
23rd Mar 201210:58 amRNSDirector/PDMR Shareholding
29th Feb 20124:54 pmRNSTotal Voting Rights
28th Feb 20127:00 amRNSAcquisition
20th Feb 20121:32 pmRNSHolding(s) in Company
16th Feb 20122:44 pmRNSDirectorate Change
2nd Feb 20127:00 amRNSInterim Management Statement
1st Feb 20122:30 pmRNSNotice of IMS
31st Jan 20125:44 pmRNSTotal Voting Rights
17th Jan 201211:04 amRNSDirector/PDMR Shareholding
29th Dec 201110:22 amRNSTotal Voting Rights
13th Dec 20113:33 pmRNSDirector/PDMR Shareholding
29th Nov 20117:00 amRNSHalf Yearly Report
22nd Nov 20112:55 pmRNSHolding(s) in Company
17th Nov 20117:00 amRNSDisposal
14th Nov 20112:20 pmRNSDirector/PDMR Shareholding
4th Nov 20114:04 pmRNSHolding(s) in Company
1st Nov 201110:27 amRNSBlocklisting Interim Review
20th Oct 20112:43 pmRNSNotice of Results
18th Oct 201110:03 amRNSAdditional Listing
13th Oct 20112:34 pmRNSDirector/PDMR Shareholding
13th Oct 20117:00 amRNSDisposal
11th Oct 201110:03 amRNSHolding(s) in Company
10th Oct 20111:10 pmRNSHolding(s) in Company
22nd Sep 20112:30 pmRNSDirector/PDMR Shareholding
21st Sep 20118:30 amRNSHolding(s) in Company
19th Sep 20111:53 pmRNSHolding(s) in Company
16th Sep 20114:57 pmRNSDirector/PDMR Shareholding
6th Sep 20114:31 pmRNSAnnual Information Update
5th Sep 20114:01 pmRNSResult of AGM
31st Aug 20115:20 pmRNSHolding(s) in Company
16th Aug 20111:09 pmRNSDirector/PDMR Shareholding
11th Aug 201110:26 amRNSNotice of AGM
10th Aug 20117:00 amRNSInterim Management Statement
1st Aug 20113:14 pmRNSNotice of IMS
14th Jul 201112:08 pmRNSAnnual Financial Report
13th Jul 20113:10 pmRNSDirector/PDMR Shareholding
6th Jul 20117:00 amRNSDirectorate Change
14th Jun 201111:18 amRNSDirector/PDMR Shareholding
10th Jun 20117:00 amRNSDisposal
9th Jun 20114:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.